InnovaCare Health was established to operate in the space of Medicare Advantage program. As a privately owned healthcare management firm, InnovaCare offers innovative medical solutions to its clients. In the same breath, the company complements the government-sponsored healthcare programs in ensuring that the entire population in Puerto Rico receives the best healthcare services. The company has a dedicated executive team led by Dr. Rick Shinto, the CEO, and Ms. Penelope Kokkinides, the CAO.
Dr. Rick Shinto
Dr. Rick Shinto is a highly experienced medical professional, especially in clinical and managed healthcare sector. His academic record speaks for itself, with three degrees- a B.S, an M.D, and an MBA- from three prestigious institutions. He also boasts of several healthcare articles to his name.
Shinto started his career in the medical sector as an intern in Southern California more than 20 years ago. His first executive role in healthcare management came through MedPartners who offered him a chance to serve as the medical management’s vice president in 1996. He quit this position a year later to take up another executive role at Cal Optima Health Plan. He worked for the Orange County-based firm as CMO until he left to join Medical Pathways Management Company as COO and CMO. Shinto’s diligent service to the company earned him a CMO role at NAMM California and later a CEO Job at Aveta Inc. in 2008. He served in this role until 2012 when he assumed his current role at InnovaCare. He also doubles up as CEO of the company’s Health Plans in Puerto Rico.
Just like Dr. Shinto, Penelope Kokkinides excelled not only in her career but also academically. She studied biological sciences at the undergraduate level at Binghamton University. For her postgraduate studies, she studied social work at the eminent University of New York and public health at revered Columbia University School of Public Health. Visit Bloomberg.com for more info on Penelope Kokkinides.
Before her current role at InnovaCare, Penelope had served as the company’s COO. She previously held executive roles at other healthcare firms, including Touchstone Health, UnitedHealth Group, Centerlight HealthCare, and Aveta Inc. Working for all these companies, Penelope has accumulated a lot of experience in managed healthcare services.
More about InnovaCare
InnovaCare operates mainly in North America. Based in Fort Lee, NJ, the health management hub reaches out to clients through its subsidiaries. InnovaCare also operates the Medicare and Medicaid plans. The company has stood out due to its ability to develop and deliver affordable medical programs to its clients.
Oncotarget has published a paper from the University of Salford showing that Vitamin C is over ten times more effective in inhibiting the growth of cancer stem cells than many other standard pharmaceuticals such as 2-DG. The paper outlined the results of a study conducted by researchers on three natural substances, three experimental medicines, and one clinical drug. This is the first study that has shown Vitamin C’s potential in targeting and killing cancer stem cells, which are responsible for fueling fatal tumors.
Dr. Michael P. Lisanti posited that his team at the University of Salford had been looking at how cancer stem cells could be targeted by natural substances such as silibinin (milk thistle), CAPE (a honey-bee derivative), and Vitamin C. He went on to assert that from the research, the results from Vitamin C were the most promising. Dr. Lisanti is the professor of translational medicine at the renowned University of Salford.
Dr. Lisanti notes that the fact that Vitamin C is effective against cancer is good news. This is because the chemical is cheap, non-toxic, and readily available. Its adoption in fighting cancer could significantly reduce the costs of therapies while saving lives.
Cancer stem-like cells have remained the major obstacle in the treatment of cancer. The cells are resistant to chemotherapy. Their resistance leads to failure of chemotherapy treatments among cancer patients. Often, this situation causes the recurrence of tumor and metastasis.
The research, which was conducted by the Salford team, hoped to look into the bioenergetics of cancer stem cells. They sought to understand the processes that allows stem cells to live and grow. They hoped to come up with a way of disrupting them. The research involved different substances: caffeic acid phenyl ester (CAPE), Silibinin, ascorbic acid, actinonin, FK866, and 2-DG. The most potent substances in the study were actinonin and FK866. Vitamin C’s potency is ten folds that of 2-DG
Oncotarget is a weekly open-source medical journal. The journal, which is published by Impact Journals, covers research on all aspects of oncology and beyond. Its editors-in-chief are Andrei Gudkov, and Mikhail Blagosklonny of Roswell Park Cancer Institute. Oncotarget was founded in 2010. Authors who seek to publish with Oncotarget benefit greatly from the peer-review conducted by the experienced reviewers. Visit Oncotarget’s profile page at facebook.com
John Goullet, the current chairman and senior manager of Diversant LLC, has a deep-rooted history in the information technology sector. From the early 80s stretching all the way to early 90s, he served in several positions in different companies within the industry. At the start of his career, he worked as an IT consultant and later as an IT account staffing executive. Some of the companies that Goulett worked for includes Computer Sciences Corp., 3d Information Services, Cap Gemini America, and The Constell Group.
John Goullet broke into the IT industry in 1994 when he used his IT staffing background to establish his company, Info Technology Inc. For the last 23 years, Info Technology has been offering professional IT staffing services to its clients. Its services are based on a deep understanding of the different staffing needs of different clients and then customized to meet those particular needs. As the CEO of Info Technologies, John Goullet has managed to grow the company to great heights. Under his leadership, the company has received recognition from Inc. magazine’s Inc. 500 for its speedy and steady growth and John’s Website.
Ideamensch interviewed John in November of last year. He said that the idea of establishing his two companies, Info Technologies and Diversant, came from his knowledge of labor markets. He revealed that the American labor market currently has a deficiency of qualified IT experts; that’s an under-explored industry. The motivation to start the companies came from the entrepreneurs who had succeeded before him. He told Ideamensch that the simple fact that they had succeeded gave him hope that he would succeed as well. Today, he grows the company by first making predictions on the future IT sector demands and then designing products for the future and learn more about John.
Worst Job for Goullet
John Goullet also discussed a bit of his past life during the interview. He narrated of a job that he did during his high school days at a local manufacturing firm. He recalled a demotivating comment that was made one of his colleague for being so hard working to the point of making the colleague feel threatened. That comment made him hate the job, and he quit a day later. To this date, that job remains as his worst ever job and read full article.
A very talented young entrepreneur, Doe Deere, who is also known as “Queen of Unicorns” shared her love for all things in multicolor and her passion for makeup industry by launching “Lime Crime” as her successful brand for cosmetic. You might have heard about the traditional success story of Doe Deere and if you are […]
Those who know George Soros cannot dispute the successful investor’s power in US politics and culture. The New York-based hedge fund manager has since the 1980s been an active funder of democratic causes around the world. His activities in the political world have helped reshape political landscapes in many countries, leading to the toppling of […]
Passive index funds will outperform active hedge funds over an extended period, according to famed investor Warren Buffett, and Capital Group CEO Timothy Armour agrees. However, in a commentary article for CNBC Investing, Armour indicates that the key to successful investing has less to do with the distinction between active and passive, and more to […]